Welcome to the first episode of our season on precision medicine in lung cancer. Today, we're exploring a pivotal breakthrough from the late 1990s—EGFR-targeted therapy—and its revolutionary impact on stage 4 lung cancer care. In this episode, we highlight the inspiring story of Wells, a cancer survivor for over 25 years, whose life was transformed by this treatment.

We’ll break down the science behind EGFR, demonstrating how targeting this biomarker has become a cornerstone in the management of metastatic NSCLC. Our aim is to empower you with the knowledge needed to engage confidently with your healthcare team as EGFR-targeted therapy continues to set the standard of care.

Whether you're a patient, a caregiver, or simply curious about cancer treatment advances, we hope this episode offers an informative and inspiring start to our deep-dive series.

See more HERE

Cre: Go2 for Lung Cancer 

#PatientSavvy